SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (4369)5/9/2003 12:04:42 PM
From: StockDung  Read Replies (2) of 5582
 
BTW, MTXX now trading at a trailing p/e of 111.5! LOL

3/2003 4/29/03 03:1 .010
2/2002 2/20/03 02:4 .030
9/2002 10/28/02 02:3 .110
6/2002 8/ 8/02 02:2 -.090
total 0.06

$6.69/0.06 = 111= p/e

Other comparable vitamin & nutirion cos (NOT biotech or pharma, remember Co says in filings that is sells "Homeopathic products" price/earnings ratios are:

NBTY (net bounty) p/e = 12.6, NATR (nature's sushine)=16.8

OME (omega protein)=10.43,NAII (Natural Alternatives Intl)= 5.4

GNC which bought RXSD (Rexall Sundown) has Dutch stock symbol of NUTV NA and a p/e of 16.5

Thus the average of these p/e is 12.34, which would imply that MTXX needs to FALL 89% to get a comparable value. That in turn implies 74 cents.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News